// App-Quantinova.ai

TCT-8 : Fate of deferred lesions using state-of-art percutaneous coronary revascularization in patients with de novo three vessel disease: lesion level analysis at 2 years of the SYNTAX II study

Researchers

Presenter

  • Norihiro Kogame

Principal Investigators

  • Manel Sabate

  • Justin Davies

  • Maciej Lesiak

  • Raul Moreno

  • Ignacio Cruz-Gonzalez

  • Nick West

  • Jan Piek

  • Yuki Katagiri

  • Taku Asano

  • Rodrigo Modolo

  • Ply Chichareon

  • Chun-Chin Chang

  • Carlos Collet

  • Javier Escaned

  • Adrian Banning

  • Yoshinobu Onuma

  • Patrick Serruys

Medical Centers

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • Belfast Health and Social Care Trust, Belfast, United Kingdom

  • Hospital Clinic Barcelona, Barcelona, Spain

  • University Hospital of Salamanca, Salamanca, Spain

  • Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland

  • Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Royal Papworth Hospital, Cambridge, United Kingdom

  • Academic Medical Center, Amsterdam, Netherlands

  • John Radcliffe Hospital, Oxford, United Kingdom.

  • Taipei Veterans General Hospital, Taipei, TAIWAN

  • Hospital Clínico San Carlos, IdISSC, Madrid, Spain

  • Imperial College, London, United Kingdom

  • University Hospital La Paz, Madrid, Spain

  • AMC, Amsterdam, Netherlands

Locations

  • Netherlands

  • Spain

  • Poland

  • Taiwan

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Chronic total occlusion

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved